InsidersTradesSigma
Paxman AB (publ) Stock: price and management transactions · Finland · FIN-FSA
Follow the Paxman AB (publ) stock price and the full insider trade history of the company, a listed equity based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Paxman AB (publ) has published 0 insider filings. Market capitalisation: €1.1bn. All data is openly available.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Paxman AB (publ) Strong Buy (bullish), based on 2 analysts. Average price target: SEK 92.50.
Fundamental score
Ranked 20,263 of 27,949 companies
36.7
score / 100
Value22
Quality51
FCF yld-1.5%
Earn yld-1.5%
EV/EBITDA36.9x
ROE-3.3%
Gross mgn67%
Net mgn-5.3%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Declarations0 total
No declarations found
0 of 0 declarations
About Paxman AB (publ)
Paxman AB (publ) is a Swedish company focused on developing solutions for managing the side effects of chemotherapy. It is listed on the Stockholm Stock Exchange (XSTO).